Skip to main content
OpenTrials

Clinical trial condition

Endometrial Atypical Hyperplasia

Explore clinical trials studying Endometrial Atypical Hyperplasia. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Atypical Hyperplasia trial results

Not yet recruiting

Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer

NCT07820358

Conditions
Body Weight, Body Weight Changes, Endometrial Atypical Hyperplasia, +26 more
Locations
  • Houston Methodist at The Medical Center Houston, Texas, United States
  • Houston Methodist Sugar Land Houston, Texas, United States
  • Houston Methodist Willowbrook Houston, Texas, United States
  • Houston Methodist Woodlands Houston, Texas, United States
View Trial Details
Completed

Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

NCT01968317

Conditions
Endometrial Adenocarcinoma, Endometrial Atypical Hyperplasia, Endometrial Hyperplasia, +6 more
Locations
  • Obstetrics and Gynecology Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Changning Maternity & Infant Health Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Sixth People's Hospital Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions